A cytokine-mediated link between innate immunity, inflammation, and cancer
Top Cited Papers
Open Access
- 1 May 2007
- journal article
- review article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 117 (5), 1175-1183
- https://doi.org/10.1172/jci31537
Abstract
It has been established that cancer can be promoted and/or exacerbated by inflammation and infections. Indeed, chronic inflammation orchestrates a tumor-supporting microenvironment that is an indispensable participant in the neoplastic process. The mechanisms that link infection, innate immunity, inflammation, and cancer are being unraveled at a fast pace. Important components in this linkage are the cytokines produced by activated innate immune cells that stimulate tumor growth and progression. In addition, soluble mediators produced by cancer cells recruit and activate inflammatory cells, which further stimulate tumor progression. However, inflammatory cells also produce cytokines that can limit tumor growth. Here we provide an overview of the current understanding of the role of inflammation-induced cytokines in tumor initiation, promotion, and progression.This publication has 131 references indexed in Scilit:
- Nuclear factor-κB in cancer development and progressionNature, 2006
- NF‐κB and cancer: Mechanisms and targetsMolecular Carcinogenesis, 2006
- Pathogen Recognition and Innate ImmunityCell, 2006
- NF-κB: linking inflammation and immunity to cancer development and progressionNature Reviews Immunology, 2005
- Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-β signalingNature Medicine, 2005
- Smad-dependent and Smad-independent pathways in TGF-β family signallingNature, 2003
- Inflammation and cancerNature, 2002
- NF-κB in cancer: from innocent bystander to major culpritNature Reviews Cancer, 2002
- Toll-like receptors and innate immunityNature Reviews Immunology, 2001
- The Hallmarks of CancerCell, 2000